Literature DB >> 15320692

1-Azaadamantanes: pharmacological applications and synthetic approaches.

H Izumi1, S Yamagami, S Futamura.   

Abstract

1-Azaadamantane (1-azatricyclo [3.3.1.1(3,7)]decane) was synthesized in 1953, and the derivatives have been used as rigid models for studies on intramolecular charge transfer phenomena, fluorescence excitation Rydberg states, highly twisted amides, solid electrolyte gas sensors, basicities, and self-organization systems. These structures have also been attracting considerable interest due to their pharmacological activities. The substituted 1-azaadamantanes as conformationally restricted amines have great potential for the therapeutic utilization as anticholinergic agents, serotonergic agents, and squalene synthase inhibitors. However, many steps have been needed for the synthesis of 1-azaadamantanes, and the concise synthetic approaches have been developed. Though double or triple Mannich reactions yield 1-azaadamantanes in moderate yields, the reduction steps are necessary. Our recent research has revealed that trifluoromethanesulfonic anhydride is available for the convenient synthesis of 1-azoniaadamantanes and 1-azaadamantanes without reduction. The new tools for the discovery of novel drugs such as quantitative structure-activity relationship (QSAR) analysis and vibrational circular dichroism (VCD) spectroscopy have also been discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15320692     DOI: 10.2174/1568016033477478

Source DB:  PubMed          Journal:  Curr Med Chem Cardiovasc Hematol Agents        ISSN: 1568-0169


  3 in total

1.  Azaadamantanes, a New Promising Scaffold for Medical Chemistry.

Authors:  E V Suslov; K Yu Ponomarev; K P Volcho; N F Salakhutdinov
Journal:  Russ J Bioorg Chem       Date:  2021-12-16       Impact factor: 0.796

2.  Synthesis of 2-Azaadamantan-6-one: A Missing Isomer.

Authors:  Jianbo Wu; Derek A Leas; Yuxiang Dong; Xiaofang Wang; Edward L Ezell; Douglas E Stack; Jonathan L Vennerstrom
Journal:  ACS Omega       Date:  2018-09-18

3.  ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.

Authors:  Satya Narayan; Srinivasa Ramisetti; Aruna S Jaiswal; Brian K Law; Ashona Singh-Pillay; Parvesh Singh; Shantu Amin; Arun K Sharma
Journal:  Eur J Med Chem       Date:  2018-10-23       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.